423 Phase 1 dose escalation, safety and pharmacokinetic study of IT-101 (CRLX101), a novel nanopharmaceutical containing camptothecin, in advanced solid tumor cancer patients

✍ Scribed by Y. Yen; T. Synold; G.J. Weiss; T. Schluep; J. Ryan

• Book ID: 119603106
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 82 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)72130-3